Lumira Ventures is Canada’s largest and most active healthcare venture capital firm that invests in North American companies developing innovative therapeutics and medical technologies whose products offer transformative improvements to patient health outcomes and meaningful reductions to the overall cost of healthcare delivery. Lumira executes a proven, differentiated investment strategy as a lead investor and active partner to its portfolio companies who are driving forward the next generation of patient care. Since inception, Lumira’s portfolio companies have brought 40+ new therapies to market, impacting the lives of 1 billion patients globally, generating $65+ billion in cumulative revenue.

Lumira executes a consistent, proven investment strategy as a lead investor and active partner with our portfolio companies. We focus on companies whose products offer transformative (not incremental) improvements to patient health outcomes, and the promise of dramatic reductions in the cost of healthcare delivery. Our Canadian heritage helps us “skate to where the puck is going to be,” investing in the new science and clinical insights that we expect will be driving the next decade of patient care.

Since our inception, we’ve been a different type of venture capital investor. We often focus on backing companies in regions of North America bypassed by most other investors. We manage right-sized funds where the financial interests of our fund investors are tightly aligned with our own. And we differentiate ourselves to entrepreneurs as an investor-of-choice by helping them leverage our multi-decade team stability, global industry relationships and lessons learned from building over 100 companies over our careers.